0001493152-17-003302.txt : 20170331 0001493152-17-003302.hdr.sgml : 20170331 20170331195916 ACCESSION NUMBER: 0001493152-17-003302 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170331 DATE AS OF CHANGE: 20170331 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VBI Vaccines Inc/BC CENTRAL INDEX KEY: 0000764195 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-830-3031 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: SciVac Therapeutics Inc. DATE OF NAME CHANGE: 20150717 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD. DATE OF NAME CHANGE: 20100910 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD DATE OF NAME CHANGE: 19850305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buckley T. Adam CENTRAL INDEX KEY: 0001615926 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37769 FILM NUMBER: 17731970 MAIL ADDRESS: STREET 1: C/O VBI VACCINES INC., STREET 2: 222 THIRD STREET, STE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 3 1 form3.xml X0206 3 2016-12-31 0 0000764195 VBI Vaccines Inc/BC VBIV 0001615926 Buckley T. Adam C/O VBI VACCINES INC. 222 THIRD STREET, STE 2241 CAMBRIDGE MA 02142 0 1 0 0 VP, Business Development Common Shares, no par value per share 39376 D Restricted Stock Units (RSUs) 0.00 2026-06-14 Common Shares 14062 D Option (Right to Buy Common Shares) 2.50 2018-03-18 Common Shares 1946 D Option (Right to Buy Common Shares) 5.06 2019-01-21 Common Shares 3735 D Option (Right to Buy Common Shares) 2.50 2022-03-29 Common Shares 5357 D Option (Right to Buy Common Shares) 2.50 2022-04-02 Common Shares 3826 D Option (Right to Buy Common Shares) 4.13 2024-07-25 Common Shares 71224 D Option (Right to Buy Common Shares) 4.93 2025-07-30 Common Shares 39015 D Each RSU represents a contingent right to receive 1 common share of the Issuer upon settlement. The RSUs vest 1/3 per year over 3 years, beginning on June 22, 2017, subject to continued service through each vesting date. The option is fully vested. The option vests 1/48th of the total shares monthly following the grant date of July 25, 2014, subject to continued service through each vesting date. The option vests 1/48th of the total shares monthly following the grant date of July 30, 2015, subject to continued service through each vesting date. /s/ T.Adam Buckley 2017-03-31